tiprankstipranks
Trending News
More News >
Astrazeneca Plc (AZN)
NASDAQ:AZN
US Market
Advertisement

AstraZeneca (AZN) Drug Pipeline

Compare
7,356 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Alxn1920
Primary Membranous Nephropathy
Phase II
Not Yet Recruiting
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Aug 28, 2025
AZD0901
Gastric Cancer, Gastroesophageal Junction Cancer
Phase II
Not Yet Recruiting
A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2
Aug 20, 2025
Carboplatin, Gemcitabine, Cisplatin, Dato-Dxd
Bladder Cancer, Urothelial Cancer
Phase II/III
Not Yet Recruiting
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Aug 12, 2025
Azd4117, Azd5315
Influenza A
Phase I/II
Not Yet Recruiting
A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)
Aug 05, 2025
Opemalirsen (Azd2373)
Renal Impairment
Phase I
Recruiting
A Phase I Study to Investigate the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)
Jul 28, 2025
Azd4512
B-Cell Non-Hodgkin Lymphoma
Phase I/II
Not Yet Recruiting
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Jul 24, 2025
Rosuvastatin, Capivasertib
Healthy Participants
Phase I
Not Yet Recruiting
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants
Jul 17, 2025
Azd0292
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Phase II
Not Yet Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
Jul 17, 2025
Metered Dose Inhaler, Budesonide/Glycopyrronium/Formoterol Fumarate
Chronic Obstructive Pulmonary Disease, Hyperinflation
Phase IV
Not Yet Recruiting
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Jul 17, 2025
Rilvegostomig, Azd6750
Renal Cell Carcinoma, Non-small Cell Lung Cancer, Triple Negative Breast Cancer, Head And Neck Squamous Cell Carcinoma, Melanoma, Merkel Cell Carcinoma, High Grade Serous Ovarian Carcinoma, Squamous Cell Carcinoma (Skin), Gastric Cancer/Gastroesophageal Junction Cancer
Phase I/II
Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Jul 16, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Astrazeneca Plc (AZN) have in its pipeline
      AZN is currently developing the following drugs: Alxn1920, AZD0901, Carboplatin, Gemcitabine, Cisplatin, Dato-Dxd. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis